Polar Capital Holdings Plc 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 09:26 am Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Polar Capital Holdings Plc | 6,297,688 6.670% |
-820,256 (-11.52%) |
Filing |
| 2023-11-16 1:13 pm Purchase |
2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Polar Capital Holdings Plc | 7,117,944 7.560% |
7,117,944 (New Position) |
Filing |